Detalhe da pesquisa
1.
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.
J Infect Dis
; 229(5): 1256-1265, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38207119
2.
Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection.
Breast Cancer Res
; 26(1): 76, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745208
3.
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Blood
; 139(8): 1177-1183, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797911
4.
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers.
J Immunol
; 208(6): 1362-1370, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228263
5.
A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
Breast Cancer Res
; 22(1): 12, 2020 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31992350
6.
Molecular heterogeneity in breast cancer: State of the science and implications for patient care.
Semin Cell Dev Biol
; 64: 65-72, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27569190
7.
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis.
Mediators Inflamm
; 2017: 4814987, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28634420
8.
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.
Proc Natl Acad Sci U S A
; 111(24): 8838-43, 2014 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24876273
9.
Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM.
Bioinformatics
; 29(13): i62-70, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23813010
10.
Quality of Life in the Phase 2/3 Trial of N-803 Plus Bacillus Calmette-Guérin in Bacillus Calmette-GuérinâUnresponsive Nonmuscle-Invasive Bladder Cancer.
Urol Pract
; 11(2): 367-375, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226931
11.
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach.
Transl Oncol
; 44: 101943, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593586
12.
Assessment of the impact of a personalised nutrition intervention in impaired glucose regulation over 26 weeks: a randomised controlled trial.
Sci Rep
; 14(1): 5428, 2024 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443427
13.
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques.
Science
; 383(6687): 1104-1111, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422185
14.
Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies.
Cells
; 12(12)2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37371081
15.
Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer.
Front Plant Sci
; 14: 1149455, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37711295
16.
Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer.
Cancer Cell
; 41(5): 887-902.e5, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059104
17.
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial.
Clin Cancer Res
; 29(13): 2456-2465, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014668
18.
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial.
Clin Cancer Res
; 29(17): 3384-3394, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432976
19.
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
NEJM Evid
; 2(1): EVIDoa2200167, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320011
20.
Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike.
Front Immunol
; 13: 918928, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35812370